Pharma Journalist -

There’s only 2 weeks to go until the 𝐍𝐞𝐮𝐫𝐨𝐩𝐚𝐭𝐡𝐢𝐜 𝐏𝐚𝐢𝐧 𝐓𝐡𝐞𝐫𝐚𝐩𝐞𝐮𝐭𝐢𝐜𝐬 𝐒𝐮𝐦𝐦𝐢𝐭 takes place online this August 24-25. Have you booked your ticket? Here are some top reasons to attend: 𝟐𝟒+ …
Read More...

GentiBio, Inc., a biotherapeutics company developing engineered regulatory T cells (Tregs) therapies for immunology,  announced it has closed on a Series A financing generating…
Read More...

C4 Therapeutics, Inc. (C4T) a clinical-stage biopharmaceutical company pioneering a new class of small-molecule medicines that selectively destroy disease-causing proteins through…
Read More...

Vensica Therapeutics ("Vensica"), a clinical stage biopharmaceutical company, announced that it has signed a strategic collaboration agreement with Merz Therapeutics, a business of the…
Read More...

Evotec SE announced the opening of the company’s late-stage clinical and commercial biologics cGMP manufacturing facility (J.POD 1 US) in Redmond, Washington. The innovative cGMP…
Read More...

Ceapro Inc. a growth-stage biotechnology company focused on the development and commercialization of active ingredients for healthcare and cosmetic industries, announced that it has…
Read More...

I-Mab a clinical-stage biopharmaceutical company committed to the discovery, development, and commercialization of novel biologics, announced positive interim data from its U.S. phase…
Read More...

Merck known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review for a new supplemental…
Read More...

AzurRx BioPharma, Inc. a company specializing in the development of targeted non-systemic, recombinant therapies for gastrointestinal (GI) diseases, announced the completion of site…
Read More...

Moderna, Inc. a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced a Memorandum of Understanding (MoU) with the government of Canada to build a…
Read More...